BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 15199752)

  • 21. Variant hairy cell leukemia following papillary urothelial neoplasm of bladder.
    Beyan C; Kaptan K
    J Coll Physicians Surg Pak; 2014 Mar; 24 Suppl 1():S27-8. PubMed ID: 24717996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hairy-cell leukemia: a rare blood disorder in Asia.
    Josephine FP; Nissapatorn V
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():190-4. PubMed ID: 17547079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful treatment by ranimustine (MCNU) of a patient with B-cell prolymphocytic leukemia (B-PLL)].
    Wake A; Yamasaki Y; Ogawa R; Mori N; Nagata K; Nakata K; Misago M; Izumi Y; Fujita K; Oda S
    Rinsho Ketsueki; 1993 Nov; 34(11):1464-9. PubMed ID: 8254909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
    Sokol L; Agosti SJ
    Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
    Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
    Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cladribine for the treatment of hairy cell leukemia and chronic lymphocytic leukemia.
    Rai KR
    Semin Oncol; 1998 Jun; 25(3 Suppl 7):19-22. PubMed ID: 9671325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A patient with a variant form of hairy cell leukaemia.
    Kramer PA; Oosterhuis WP; van Kammen E; Hazenberg BP; Balhuizen JC; Dinkelaar RB
    Neth J Med; 1993 Dec; 43(5-6):262-8. PubMed ID: 8107934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular study of hairy cell leukemia variant with biclonal paraproteinemia.
    Copeland AR; Bueso-Ramos C; Liu FJ; Kornblau SM; Huh YO; Albitar M
    Arch Pathol Lab Med; 1997 Feb; 121(2):150-4. PubMed ID: 9126043
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hairy cell leukemia: current concepts.
    Cannon T; Mobarek D; Wegge J; Tabbara IA
    Cancer Invest; 2008 Oct; 26(8):860-5. PubMed ID: 18798068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A hairy B cell lymphoproliferative disorder resembling hairy cell leukemia].
    Yagi Y; Sakabe H; Kakinoki R; Yoshikawa K; Inoue T; Fujiyama Y; Machii T
    Rinsho Ketsueki; 2004 Apr; 45(4):312-5. PubMed ID: 15168448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An otherwise typical case of non-Japanese hairy cell leukemia with CD10 and CDw75 expression: response to cladaribine phosphate therapy.
    Dunphy CH; Oza YV; Skelly ME
    J Clin Lab Anal; 1999; 13(4):141-4. PubMed ID: 10414592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Successful rituximab treatment in a patient with refractory hairy cell leukemia-Japanese variant and suffering from acute respiratory distress].
    Makita M; Nakamura K; Kono A
    Rinsho Ketsueki; 2005 Nov; 46(11):1196-201. PubMed ID: 16440803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hairy cell leukemia-variant--a case report.
    Gupta K; Jasmina A; Malhotra P; Varma N; Vaiphei K; Vohra H; Varma S; Garewal G
    Indian J Pathol Microbiol; 2005 Jul; 48(3):387-9. PubMed ID: 16761764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective treatment of a refractory hairy cell leukemia variant with splenic pre-irradiation and alemtuzumab.
    Sasaki M; Sugimoto K; Mori T; Karasawa K; Oshimi K
    Acta Haematol; 2008; 119(1):48-53. PubMed ID: 18259114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
    Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
    Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cladribine (2-chlorodeoxyadenosine) therapy in hairy cell leukemia variant. A report of three cases.
    Palomera L; Domingo JM; Sola C; Azaceta G; Calvo MT; Gutierrez M
    Haematologica; 2002 Jan; 87(1):107-8. PubMed ID: 11801472
    [No Abstract]   [Full Text] [Related]  

  • 38. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO; de Castro C
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hairy-cell leukemia: current views.
    Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A
    Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hairy cell leukemia: treatment successes in the past 25 years.
    Golomb HM
    J Clin Oncol; 2008 Jun; 26(16):2607-9. PubMed ID: 18509168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.